ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 175 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,580,000 | -12.7% | 39,700 | -7.7% | 0.21% | -34.1% |
| Q2 2021 | $4,100,000 | -45.4% | 43,000 | -34.8% | 0.32% | -50.5% |
| Q1 2021 | $7,515,000 | -39.0% | 66,000 | -25.8% | 0.65% | -32.4% |
| Q4 2020 | $12,319,000 | +90.7% | 89,000 | +13.2% | 0.96% | +82.4% |
| Q3 2020 | $6,460,000 | +4.5% | 78,600 | -0.5% | 0.53% | -33.8% |
| Q2 2020 | $6,180,000 | +261.2% | 79,000 | +105.2% | 0.80% | +143.6% |
| Q1 2020 | $1,711,000 | +640.7% | 38,500 | +612.7% | 0.33% | +628.9% |
| Q4 2019 | $231,000 | -87.0% | 5,402 | -80.7% | 0.04% | -87.1% |
| Q2 2019 | $1,778,000 | +66.9% | 28,000 | +169.2% | 0.35% | -27.3% |
| Q2 2015 | $1,065,000 | – | 10,400 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |